Skip to content
Back to resident companies

Morphitectica

Investment areas

  • Biotech / Life Sciences
  • Manufacturing
  • Materials
  • Space
Founders & Leadership
Gizem Gumuskaya
Headquarters
Cambridge, MA

Reprogramming biological cells to build structures where machines can’t.

The Tough Tech problem we are solving

Construction drives 40% of global emissions via carbon-intensive materials, skilled labor, and heavy machinery, rendering it infeasible for remote or space environments. Biofabrication approaches still depend on molds, casts, and 3D printers, undermining biology's autonomous, self-shaping potential and perpetuating high costs and logistics.

About our solution

Morphitectica pioneers synthetic morphogenesis to reprogram living cells for autonomous growth into precise architectural components, lightweight load-bearing bricks, modular panels, and adaptive structures, from compact biological "seeds." This replaces tons of materials with grams of seeds, eliminating cranes, emissions, and assembly while enabling ultra-low-carbon, in-situ construction on Earth and beyond.